We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03142334
Brief Title: Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3475-564/KEYNOTE-564)

First Submitted : May 3, 2017
First Submitted that Met QC Criteria : May 3, 2017
First Posted : May 5, 2017

Results First Submitted : November 29, 2021
Results First Submitted that Met QC Criteria : November 29, 2021
Results First Posted : December 28, 2021

Last Update Submitted that Met QC Criteria : November 29, 2021
Last Update Posted : December 28, 2021